{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:10:44Z","timestamp":1787317844213,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.msard.2023.104730","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:02:13Z","timestamp":1682337733000},"page":"104730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-681X","authenticated-orcid":false,"given":"Marco A.","family":"Lana-Peixoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia C.","family":"Talim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagoberto","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Daccath","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Magno","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-0567","authenticated-orcid":false,"given":"Vinicius A.","family":"Schoeps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2023.104730_bib0001","doi-asserted-by":"crossref","first-page":"13890","DOI":"10.1038\/s41598-020-70919-w","article-title":"Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"10","author":"Akaishi","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.msard.2023.104730_bib0002","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00415-009-5288-y","article-title":"Two cases of benign neuromyelitis optica in patients with celiac disease","volume":"256","author":"Bergamaschi","year":"2009","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.104730_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.msard.2014.09.211","article-title":"Health-related quality of life in patients with longstanding 'benign multiple sclerosis","volume":"4","author":"Bueno","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2023.104730_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2023.104730_bib0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/1352458512463767","article-title":"Low degree of cortical pathology is associated with benign course of multiple sclerosis","volume":"19","author":"Calabrese","year":"2013","journal-title":"Mult. Scler."},{"issue":"14","key":"10.1016\/j.msard.2023.104730_bib0006","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1177\/13524585221114997","article-title":"Overall disability response score: an integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis","volume":"28","author":"Chang","year":"2022","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2023.104730_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archneurol.2011.127","article-title":"A benign form of neuromyelitis optica: does it exist?","volume":"68","author":"Collongues","year":"2011","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104730_bib0008","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11910-012-0292-5","article-title":"Benign multiple sclerosis: does it exist?","volume":"12","author":"Correale","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"7","key":"10.1016\/j.msard.2023.104730_bib0009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp-2018-319913","article-title":"Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study","volume":"90","author":"Crielaard","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ane.12442","article-title":"Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions","volume":"133","author":"Gajofatto","year":"2016","journal-title":"Acta Neurol. Scand."},{"issue":"10","key":"10.1016\/j.msard.2023.104730_bib0011","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2023.104730_bib0012","doi-asserted-by":"crossref","first-page":"e79083","DOI":"10.1371\/journal.pone.0079083","article-title":"An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays","volume":"8","author":"Hoftberger","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"Cloud-like enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.104730_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.msard.2023.104730_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0016","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.msard.2015.04.001","article-title":"On the origin of neurostatus","volume":"4","author":"Kappos","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2023.104730_bib0017","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/1352458511412995","article-title":"Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients","volume":"17","author":"Ketelslegers","year":"2011","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2023.104730_bib0018","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.msard.2023.104730_bib0019","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2023.104730_bib0020","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1352458516674366","article-title":"Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G","volume":"23","author":"Kim","year":"2017","journal-title":"Mult. Scler."},{"issue":"Pt 6","key":"10.1016\/j.msard.2023.104730_bib0021","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2023.104730_bib0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00415-006-0116-0","article-title":"A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings","volume":"253","author":"Koller","year":"2006","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0023","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1352458512456613","article-title":"Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study","volume":"19","author":"Leray","year":"2013","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0024","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"issue":"Pt 7","key":"10.1016\/j.msard.2023.104730_bib0025","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104730_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102522","article-title":"Risk of relapse in patients with neuromyelitis optica spectrum disorder: recognition and preventive strategy","volume":"46","author":"Ma","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2023.104730_bib0027","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1177\/13524585221102587","article-title":"Grey-matter sodium concentration as an individual marker of multiple sclerosis severity","volume":"28","author":"Maarouf","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104730_bib0028","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2023.104730_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104414","article-title":"Neuromyelitis optica: clinical course and potential prognostic indicators","volume":"69","author":"Masha","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.msard.2023.104730_bib0030","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s00415-021-10501-0","article-title":"Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course","volume":"268","author":"Mathey","year":"2021","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0031","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1212\/NXI.0000000000000134","article-title":"Update on biomarkers in neuromyelitis optica","volume":"2","author":"Melamed","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0032","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"issue":"Pt 5","key":"10.1016\/j.msard.2023.104730_bib0033","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104730_bib0034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2377-10-45","article-title":"Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis","volume":"10","author":"Nakajima","year":"2010","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.msard.2023.104730_bib0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1352458509103301","article-title":"Occurrence of acute large and edematous callosal lesions in neuromyelitis optica","volume":"15","author":"Nakamura","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104730_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103280","article-title":"Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis","volume":"56","author":"Niiranen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2023.104730_bib0037","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(14)70264-9","article-title":"Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives","volume":"14","author":"Ontaneda","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104730_bib0038","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0039","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1212\/NXI.0000000000000351","article-title":"Spontaneous remission lasting more than a decade in untreated AQP4 antibody-positive NMOSD","volume":"4","author":"Pandit","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2023.104730_bib0040","doi-asserted-by":"crossref","first-page":"e17063","DOI":"10.1371\/journal.pone.0017063","article-title":"The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected","volume":"6","author":"Pena","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.msard.2023.104730_bib0041","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0404.2006.00637.x","article-title":"Benign course in multiple sclerosis: a review","volume":"113","author":"Ramsaransing","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2023.104730_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102718","article-title":"Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience","volume":"48","author":"Rempe","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104730_bib0043","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ensci.2017.05.002","article-title":"Definition, prevalence and predictive factors of benign multiple sclerosis","volume":"7","author":"Reynders","year":"2017","journal-title":"eNeurologicalSci"},{"issue":"Pt 5","key":"10.1016\/j.msard.2023.104730_bib0044","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2023.104730_bib0045","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s00415-017-8487-y","article-title":"Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study","volume":"264","author":"Sartori","year":"2017","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2023.104730_bib0046","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/01.wnl.0000253185.03943.66","article-title":"Longitudinal follow-up of \"benign\" multiple sclerosis at 20 years","volume":"68","author":"Sayao","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2023.104730_bib0047","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archopht.1949.00900050473014","article-title":"Neuromyelitis optica; presentation of five cases, with pathologic study, and review of literature","volume":"42","author":"Stansbury","year":"1949","journal-title":"Arch. Ophthal."},{"issue":"9","key":"10.1016\/j.msard.2023.104730_bib0048","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/1352458514560927","article-title":"Benign neuromyelitis optica is rare in Japanese patients","volume":"21","author":"Uzawa","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0049","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen3.12107","article-title":"Evaluation of aquaporin-4 antibody assays","volume":"5","author":"Waters","year":"2014","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"Pt 1","key":"10.1016\/j.msard.2023.104730_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","article-title":"The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104730_bib0051","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2741\/1267","article-title":"Neuromyelitis optica: current concepts","volume":"9","author":"Wingerchuk","year":"2004","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.msard.2023.104730_bib0052","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2023.104730_bib0053","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0054","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WCO.0b013e3280be58d8","article-title":"Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis","volume":"20","author":"Wingerchuk","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2023.104730_bib0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2023.104730_bib0056","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2023.104730_bib0057","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458513495581","article-title":"Bright spotty lesions\" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis","volume":"20","author":"Yonezu","year":"2014","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823002341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823002341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:10:21Z","timestamp":1761901821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":57,"alternative-id":["S2211034823002341"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104730","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104730"}}